Premium
Hybrid coronary revascularization: Time for a new comparator?
Author(s) -
Misumida Naoki,
Moliterno David J.
Publication year - 2018
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27503
Subject(s) - medicine , revascularization , conventional pci , cardiology , perioperative , surgery , myocardial infarction
Key Points The present meta‐analysis found no significant difference between hybrid coronary revascularization (HCR) and bypass surgery (CABG) regarding intermediate‐term major adverse cardiac and cerebrovascular events. HCR is feasible, historically with higher revascularization rates but less perioperative morbidity With a comparable frequency of repeat revascularization between current‐generation drug‐eluting stents and CABG, future trials of HCR are considering multi‐vessel PCI as the new comparator.